Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review
Hsiangkuo Yuan, Nicole Spare, Stephen D. Silberstein
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. S2, pp. 20-32
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Innovations and advances in modelling and measuring pain in animals
Katelyn E. Sadler, Jeffrey S. Mogil, Cheryl L. Stucky
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 70-85
Open Access | Times Cited: 119
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
Faraidoon Haghdoost, Francesca Puledda, David García-Azorí­n, et al.
Cephalalgia (2023) Vol. 43, Iss. 4
Open Access | Times Cited: 76
A Female-Specific Role for Calcitonin Gene-Related Peptide (CGRP) in Rodent Pain Models
Candler Paige, Isabel Plasencia-Fernández, Moeno Kume, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 10, pp. 1930-1944
Open Access | Times Cited: 75
New and Emerging Treatments for the Acute and Preventive Therapy of Migraine and Other Headaches
Todd J. Schwedt
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. S2, pp. 1-2
Open Access | Times Cited: 126
Macrophage as a Peripheral Pain Regulator
Risa Domoto, Fumiko Sekiguchi, Maho Tsubota, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1881-1881
Open Access | Times Cited: 100
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 2, pp. 465-473
Open Access | Times Cited: 11
Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine—The monoclonal antibodies and gepants
Chia‐Chun Chiang, Todd J. Schwedt
Progress in brain research (2020), pp. 143-170
Closed Access | Times Cited: 61
The neuropeptide calcitonin gene-related peptide alpha is essential for bone healing
Jessika Appelt, Anke Baranowsky, Denise Jahn, et al.
EBioMedicine (2020) Vol. 59, pp. 102970-102970
Open Access | Times Cited: 58
Calcitonin Gene-Related Peptide (CGRP) and Cluster Headache
Andrea Carmine Belin, Caroline Ran, Lars Edvinsson
Brain Sciences (2020) Vol. 10, Iss. 1, pp. 30-30
Open Access | Times Cited: 56
A link between gastrointestinal disorders and migraine: Insights into the gut–brain connection
Sheena K. Aurora, Stephen B. Shrewsbury, Sutapa Ray, et al.
Headache The Journal of Head and Face Pain (2021) Vol. 61, Iss. 4, pp. 576-589
Open Access | Times Cited: 55
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein
BioDrugs (2022) Vol. 36, Iss. 3, pp. 341-358
Open Access | Times Cited: 29
Cluster headache: an update on clinical features, epidemiology, pathophysiology, diagnosis, and treatment
Daniel San‐Juan, Karina Vélez-Jiménez, Jan Hoffmann, et al.
Frontiers in Pain Research (2024) Vol. 5
Open Access | Times Cited: 6
Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor
Hans‐Christoph Diener, Stefanie Förderreuther, Charly Gaul, et al.
Neurological Research and Practice (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 43
Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
Andreas Yiangou, James Mitchell, Claire Fisher, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 61, Iss. 1, pp. 157-169
Open Access | Times Cited: 41
The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
Fred Cohen, Hsiangkuo Yuan, Ellen Michelle Gibson DePoy, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 922-930
Open Access | Times Cited: 25
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
Xinyu Tao, Zeya Yan, Jiahao Meng, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Emerging themes in idiopathic intracranial hypertension
Olivia Grech, Susan P. Mollan, Benjamin R. Wakerley, et al.
Journal of Neurology (2020) Vol. 267, Iss. 12, pp. 3776-3784
Open Access | Times Cited: 39
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
León F. Garcı́a-Martı́nez, Carol J. Raport, Ethan W. Ojala, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 374, Iss. 1, pp. 93-103
Open Access | Times Cited: 34
Costs and Utilization of New-to-Market Neurologic Medications
Evan L. Reynolds, Gary W. Gallagher, Chloé E. Hill, et al.
Neurology (2022) Vol. 100, Iss. 9
Open Access | Times Cited: 20
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes
Arne May, Rafael Benoliel, Yoshiki Imamura, et al.
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 12
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptide
Justin D. Boyd, Shixia Wang, Hsiao‐Wen Lin, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review
Cecilia Rustichelli, Flavia Lo Castro, Carlo Baraldi, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 11, pp. 1269-1275
Open Access | Times Cited: 31
An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
Ivan Urits, Gavin Clark, Daniel An, et al.
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 195-215
Open Access | Times Cited: 28
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management
Andreas A. Argyriou, Dimos D. Mitsikostas, Elisa Mantovani, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 4, pp. 475-490
Closed Access | Times Cited: 24
A real‐world prospective observational study of eptinezumab in Asian patients with migraine
Yi Jing Zhao, Jonathan Ong, Sumit Kumar Sonu, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 810-824
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top